FRT [MARKET PERFORM +0.3%] - Positive pharmacy progress prompts our re-rating - Update

We upgrade our rating from UNDERPERFORM to MARKET PERFORM and raise our target price by 65% primarily due to our view that FRT’s Long Chau (LC) pharmacy chain has graduated from its start-up phase and has now moved to a phase of sustainable growth and market consolidation.